GENE ONLINE|News &
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
The war against cancer is far from over, but modern medicine has made significant progress in winning some critical battles. Thanks to the rise of new modalities, cancer diagnosis and treatment have seen practice-changing advances. Liquid biopsy, the latest entrant to precision oncology, enables the screening of cancer prevalence and detects multiple cancers with a single blood test. However, there is merit in choosing to tackle one cancer at a time using a multi-pronged approach, says Dr. Jimmy Lin, Chief Scientific Officer of Freenome.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
